{"id":4094,"date":"2023-04-24T14:10:36","date_gmt":"2023-04-24T18:10:36","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=4094"},"modified":"2026-04-13T15:19:51","modified_gmt":"2026-04-13T19:19:51","slug":"aptamers-that-bind-to-a-transmembrane-receptor","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/aptamers-that-bind-to-a-transmembrane-receptor\/","title":{"rendered":"Aptamers for Transmembrane Receptor"},"content":{"rendered":"<p>NeoVentures est heureux d'annoncer qu'un projet \u00e0 long terme avec une entreprise du Fortune 500 concernant le d\u00e9veloppement d'un aptam\u00e8re qui se lie \u00e0 un r\u00e9cepteur transmembranaire est actuellement en cours d'examen par la FDA. Ce projet pluriannuel a \u00e9t\u00e9 confi\u00e9 \u00e0 NeoVentures en raison de notre expertise dans la s\u00e9lection d'aptam\u00e8res qui induisent soit l'endocytose en se liant aux r\u00e9cepteurs transmembranaires sur des cellules cibles sp\u00e9cifiques, soit ne provoquent pas l'endocytose et ont donc la capacit\u00e9 de bloquer l'entr\u00e9e cellulaire des \u00e9l\u00e9ments infectieux. NeoVentures a \u00e9galement fourni une analyse transcriptomique approfondie de l'effet de l'aptam\u00e8re sur l'expression g\u00e9nique dans les cellules cibl\u00e9es, et a apport\u00e9 son soutien dans l'\u00e9laboration de la soumission \u00e0 la FDA.<\/p>\n<p>Cette annonce ne concerne qu'un des nombreux projets que NeoVentures a r\u00e9ussi \u00e0 livrer dans ce domaine. Nous travaillons actuellement avec nos partenaires pour concr\u00e9tiser commercialement d'autres aptam\u00e8res que nous avons d\u00e9velopp\u00e9s pour les r\u00e9cepteurs transmembranaires, soit en tant que vecteurs pour la livraison de m\u00e9dicaments, soit en tant qu'inhibiteurs de l'infection.<\/p>\n<p>Pour en savoir plus sur la capacit\u00e9 de d\u00e9veloppement d'aptam\u00e8res <a href=\"https:\/\/neoaptamers.com\/fr\/contact-us\/\">veuillez nous contacter pour une consultation gratuite.<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>NeoVentures is pleased to announce that a long term project with a Fortune 500 company regarding the development of an aptamer that binds to a transmembrane receptor is currently under review by the FDA. This multi-year project was contracted to NeoVentures because of our expertise with the selection of aptamers that either induce endocytosis by&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/aptamers-that-bind-to-a-transmembrane-receptor\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">Aptamers for Transmembrane Receptor<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":4095,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-4094","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aptamers for Transmembrane Receptor<\/title>\n<meta name=\"description\" content=\"NeoVentures announces FDA review of aptamers for transmembrane receptor developed for a Fortune 500 partner.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/aptamers-that-bind-to-a-transmembrane-receptor\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptamers for Transmembrane Receptor\" \/>\n<meta property=\"og:description\" content=\"NeoVentures announces FDA review of aptamers for transmembrane receptor developed for a Fortune 500 partner.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/aptamers-that-bind-to-a-transmembrane-receptor\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-24T18:10:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T19:19:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/04\/Untitled-design-15.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Aptamers for Transmembrane Receptor\",\"datePublished\":\"2023-04-24T18:10:36+00:00\",\"dateModified\":\"2026-04-13T19:19:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/\"},\"wordCount\":171,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Untitled-design-15.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/\",\"name\":\"Aptamers for Transmembrane Receptor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Untitled-design-15.png\",\"datePublished\":\"2023-04-24T18:10:36+00:00\",\"dateModified\":\"2026-04-13T19:19:51+00:00\",\"description\":\"NeoVentures announces FDA review of aptamers for transmembrane receptor developed for a Fortune 500 partner.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Untitled-design-15.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/Untitled-design-15.png\",\"width\":1000,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-that-bind-to-a-transmembrane-receptor\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptamers for Transmembrane Receptor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptamers for Transmembrane Receptor","description":"NeoVentures announces FDA review of aptamers for transmembrane receptor developed for a Fortune 500 partner.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/aptamers-that-bind-to-a-transmembrane-receptor\/","og_locale":"fr_FR","og_type":"article","og_title":"Aptamers for Transmembrane Receptor","og_description":"NeoVentures announces FDA review of aptamers for transmembrane receptor developed for a Fortune 500 partner.","og_url":"https:\/\/neoaptamers.com\/fr\/aptamers-that-bind-to-a-transmembrane-receptor\/","og_site_name":"neoaptamers","article_published_time":"2023-04-24T18:10:36+00:00","article_modified_time":"2026-04-13T19:19:51+00:00","og_image":[{"width":1000,"height":600,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/04\/Untitled-design-15.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Aptamers for Transmembrane Receptor","datePublished":"2023-04-24T18:10:36+00:00","dateModified":"2026-04-13T19:19:51+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/"},"wordCount":171,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/04\/Untitled-design-15.png","articleSection":["Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/","url":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/","name":"Aptamers for Transmembrane Receptor","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/04\/Untitled-design-15.png","datePublished":"2023-04-24T18:10:36+00:00","dateModified":"2026-04-13T19:19:51+00:00","description":"NeoVentures announces FDA review of aptamers for transmembrane receptor developed for a Fortune 500 partner.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/04\/Untitled-design-15.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/04\/Untitled-design-15.png","width":1000,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/aptamers-that-bind-to-a-transmembrane-receptor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Aptamers for Transmembrane Receptor"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=4094"}],"version-history":[{"count":3,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4094\/revisions"}],"predecessor-version":[{"id":6517,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/4094\/revisions\/6517"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/4095"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=4094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=4094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=4094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}